The emerging importance of group II PAKs.

The Rho-family GTPases Rho Rac and Cdc42 regulate many intracellular processes through their interaction with downstream effector proteins. The PAKs (p21-activated kinases) are a family of effector proteins for Rac and Cdc42. PAKs are important regulators of actin cytoskeletal dynamics, neurite outgrowth, cell survival, hormone signalling and gene transcription. There are six mammalian PAKs that can be divided into two groups: group I PAKs (PAK1-3) and group II PAKs (PAK4-6). Although the two PAK groups are architecturally similar, there are differences in their mode of regulation, suggesting that their cellular functions are likely to be different. Whereas much is known about group I PAKs, less is known about the more recently discovered PAK4, PAK5 and PAK6. This review will focus on the latest structural and functional results relating to the group II PAKs and discuss the emerging importance of group II PAKs in disease progression.

[1]  J. Inazawa,et al.  Identification of PAK4 as a putative target gene for amplification within 19q13.12‐q13.2 in oral squamous‐cell carcinoma , 2009, Cancer science.

[2]  B. Jiang,et al.  P21‐activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration , 2009, International journal of cancer.

[3]  S. Knapp,et al.  Targeting group II PAKs in cancer and metastasis , 2009, Cancer and Metastasis Reviews.

[4]  Gerald C. Chu,et al.  Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer , 2008, Proceedings of the National Academy of Sciences.

[5]  J. Waschke,et al.  The Drosophila p21-activated kinase Mbt modulates DE-cadherin-mediated cell adhesion by phosphorylation of Armadillo. , 2008, The Biochemical journal.

[6]  J. Kendall,et al.  Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification , 2008, Cancer biology & therapy.

[7]  Michelle Jobes,et al.  Targeted disruption of the Pak5 and Pak6 genes in mice leads to deficits in learning and locomotion. , 2008, Developmental biology.

[8]  R. Kaur,et al.  Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins , 2008, The Prostate.

[9]  A. Thrasher,et al.  WASP and WIP regulate podosomes in migrating leukocytes , 2008, Journal of microscopy.

[10]  J. Frost,et al.  p21 activated kinase 5 activates Raf‐1 and targets it to mitochondria , 2008, Journal of cellular biochemistry.

[11]  T. Suuronen,et al.  ROCK, PAK, and Toll of synapses in Alzheimer's disease. , 2008, Biochemical and biophysical research communications.

[12]  J. Masters,et al.  A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF. , 2008, Cellular signalling.

[13]  A. Minden,et al.  The Pak4 Protein Kinase Plays a Key Role in Cell Survival and Tumorigenesis in Athymic Mice , 2008, Molecular Cancer Research.

[14]  S. Choi,et al.  Gene Expression Profiles in Gallbladder Cancer: The Close Genetic Similarity Seen for Early and Advanced Gallbladder Cancers May Explain the Poor Prognosis , 2008, Tumor Biology.

[15]  G. Davis,et al.  Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling , 2008, Journal of Cell Science.

[16]  E. Dammer,et al.  Phosphorylation of CtBP1 by cAMP-dependent Protein Kinase Modulates Induction of CYP17 by Stimulating Partnering of CtBP1 and 2* , 2008, Journal of Biological Chemistry.

[17]  Luis E. Arias-Romero,et al.  A tale of two Paks , 2008, Biology of the cell.

[18]  M. Gardel,et al.  PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility , 2008, The Journal of cell biology.

[19]  F. Gillardon,et al.  Functional protein kinase arrays reveal inhibition of p‐21‐activated kinase 4 by α‐synuclein oligomers , 2007, Journal of neurochemistry.

[20]  Patrick W. Faloon,et al.  A βPix–Pak2a signaling pathway regulates cerebral vascular stability in zebrafish , 2007, Proceedings of the National Academy of Sciences.

[21]  Tomoaki Koga,et al.  Opposing roles of PAK2 and PAK4 in synergistic induction of MUC5AC mucin by bacterium NTHi and EGF. , 2007, Biochemical and biophysical research communications.

[22]  B. Foster,et al.  Up‐regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia , 2007, The Journal of pathology.

[23]  S. Elmore.  Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[24]  S. Knapp,et al.  Specificity Profiling of Pak Kinases Allows Identification of Novel Phosphorylation Sites* , 2007, Journal of Biological Chemistry.

[25]  K. Hahn,et al.  GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases. , 2007, Developmental cell.

[26]  T. Schilling,et al.  Inca: a novel p21-activated kinase-associated protein required for cranial neural crest development , 2007, Development.

[27]  G. Behre,et al.  Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPα by inhibiting its ubiquitination , 2007, Oncogene.

[28]  S. Knapp,et al.  Crystal Structures of the p21-Activated Kinases PAK4, PAK5, and PAK6 Reveal Catalytic Domain Plasticity of Active Group II PAKs , 2007, Structure.

[29]  J. Frost,et al.  Multiple Rho proteins regulate the subcellular targeting of PAK5. , 2006, Biochemical and biophysical research communications.

[30]  G. Rosenberger,et al.  PAK4 and αPIX determine podosome size and number in macrophages through localized actin regulation , 2006, Journal of cellular physiology.

[31]  Juan Iovanna,et al.  Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  E. Mandelkow,et al.  Signaling from MARK to Tau: Regulation, Cytoskeletal Crosstalk, and Pathological Phosphorylation , 2006, Neurodegenerative Diseases.

[33]  G. Jenster,et al.  Novel FXXFF and FXXMF Motifs in Androgen Receptor Cofactors Mediate High Affinity and Specific Interactions with the Ligand-binding Domain* , 2006, Journal of Biological Chemistry.

[34]  Anupama E. Gururaj,et al.  p21-activated kinases in cancer , 2006, Nature Reviews Cancer.

[35]  J. Chernoff,et al.  Nucleocytoplasmic Shuttling of Pak5 Regulates Its Antiapoptotic Properties , 2006, Molecular and Cellular Biology.

[36]  G. Bokoch,et al.  GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[37]  C. Shults.  Lewy bodies. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Chunxiang Zhang,et al.  Counter-Regulatory Function of Protein Tyrosine Phosphatase 1B in Platelet-Derived Growth Factor– or Fibroblast Growth Factor–Induced Motility and Proliferation of Cultured Smooth Muscle Cells and in Neointima Formation , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[39]  A. Minden,et al.  Pak4 Induces Premature Senescence via a Pathway Requiring p16INK4/p19ARF and Mitogen-Activated Protein Kinase Signaling , 2005, Molecular and Cellular Biology.

[40]  A. Minden,et al.  PAK4 Functions in Tumor Necrosis Factor (TNF) α-induced Survival Pathways by Facilitating TRADD Binding to the TNF Receptor* , 2005, Journal of Biological Chemistry.

[41]  E. Mandelkow,et al.  PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin. , 2005, Molecular biology of the cell.

[42]  J. Ptak,et al.  Colorectal cancer: Mutations in a signalling pathway , 2005, Nature.

[43]  Michael McClelland,et al.  Survey of differentially methylated promoters in prostate cancer cell lines. , 2005, Neoplasia.

[44]  M. Gishizky,et al.  PAK4 mediates morphological changes through the regulation of GEF-H1 , 2005, Journal of Cell Science.

[45]  Jürgen Borlak,et al.  RSK4 and PAK5 Are Novel Candidate Genes in Diabetic Rat Kidney and Brain , 2005, Molecular Pharmacology.

[46]  J. Bamburg,et al.  Interplay between components of a novel LIM kinase–slingshot phosphatase complex regulates cofilin , 2005, The EMBO journal.

[47]  R. Kaur,et al.  Activation of p21-activated Kinase 6 by MAP Kinase Kinase 6 and p38 MAP Kinase* , 2005, Journal of Biological Chemistry.

[48]  E. Perlas,et al.  The actin depolymerizing factor n-cofilin is essential for neural tube morphogenesis and neural crest cell migration. , 2005, Developmental biology.

[49]  Colleen Nelson,et al.  Mechanisms of the development of androgen independence in prostate cancer , 2005, World Journal of Urology.

[50]  N. Morin,et al.  Xenopus p21-activated kinase 5 regulates blastomeres' adhesive properties during convergent extension movements. , 2005, Developmental biology.

[51]  J. Condeelis,et al.  Cofilin takes the lead , 2005, Journal of Cell Science.

[52]  H. Chou,et al.  Wiskott–Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cells , 2004, The Journal of pathology.

[53]  Mingyao Liu,et al.  GEFT, A Rho Family Guanine Nucleotide Exchange Factor, Regulates Neurite Outgrowth and Dendritic Spine Formation* , 2004, Journal of Biological Chemistry.

[54]  Sampsa Hautaniemi,et al.  High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer. , 2004, Neoplasia.

[55]  J. Condeelis,et al.  Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation , 2004, The Journal of cell biology.

[56]  C. Dermardirossian,et al.  p21-activated Kinase 1 Phosphorylates and Regulates 14-3-3 Binding to GEF-H1, a Microtubule-localized Rho Exchange Factor* , 2004, Journal of Biological Chemistry.

[57]  C. Hung,et al.  Roles of microtubules, cell polarity and adhesion in electric-field-mediated motility of 3T3 fibroblasts , 2004, Journal of Cell Science.

[58]  J. Gutkind,et al.  Direct Interaction of p21-Activated Kinase 4 with PDZ-RhoGEF, a G Protein-linked Rho Guanine Exchange Factor* , 2004, Journal of Biological Chemistry.

[59]  G. Bokoch,et al.  Mechanism of p21-activated Kinase 6-mediated Inhibition of Androgen Receptor Signaling* , 2004, Journal of Biological Chemistry.

[60]  G. Borisy,et al.  Cell Migration: Integrating Signals from Front to Back , 2003, Science.

[61]  A. Minden,et al.  Targeted Disruption of the Gene for the PAK5 Kinase in Mice , 2003, Molecular and Cellular Biology.

[62]  R. Bronson,et al.  PAK4 Kinase Is Essential for Embryonic Viability and for Proper Neuronal Development , 2003, Molecular and Cellular Biology.

[63]  H. Kung,et al.  Identification of an Autoinhibitory Domain of p21-activated Protein Kinase 5* , 2003, Journal of Biological Chemistry.

[64]  J. Chernoff,et al.  p21-Activated Kinase 5 (Pak5) Localizes to Mitochondria and Inhibits Apoptosis by Phosphorylating BAD , 2003, Molecular and Cellular Biology.

[65]  D. Sacks,et al.  IQGAP proteins are integral components of cytoskeletal regulation , 2003, EMBO reports.

[66]  Y. Devaux,et al.  p21-activated Protein Kinase 4 (PAK4) Interacts with the Keratinocyte Growth Factor Receptor and Participates in Keratinocyte Growth Factor-mediated Inhibition of Oxidant-induced Cell Death* , 2003, The Journal of Biological Chemistry.

[67]  M. Bailly,et al.  Polarised Migration: Cofilin Holds the Front , 2003, Current Biology.

[68]  Irina Kaverina,et al.  Microtubules meet substrate adhesions to arrange cell polarity. , 2003, Current opinion in cell biology.

[69]  A. Abo,et al.  PAK4 is activated via PI3K in HGF-stimulated epithelial cells , 2002, Journal of Cell Science.

[70]  M. Rosenfeld,et al.  Transcription corepressor CtBP is an NAD(+)-regulated dehydrogenase. , 2002, Molecular cell.

[71]  S. Strömblad,et al.  p21-activated kinase 4 interacts with integrin αvβ5 and regulates αvβ5-mediated cell migration , 2002, The Journal of cell biology.

[72]  J. Chernoff,et al.  p21-activated kinases: three more join the Pak. , 2002, The international journal of biochemistry & cell biology.

[73]  Troels Z. Kristiansen,et al.  Cloning and characterization of PAK5, a novel member of mammalianp21-activated kinase-II subfamily that is predominantly expressed in brain , 2002, Oncogene.

[74]  G. Bokoch,et al.  Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton , 2002, Nature Cell Biology.

[75]  D. Whyte,et al.  Requirement for PAK4 in the Anchorage-independent Growth of Human Cancer Cell Lines* , 2002, The Journal of Biological Chemistry.

[76]  N. Nath,et al.  PAK5, a New Brain-Specific Kinase, Promotes Neurite Outgrowth in N1E-115 Cells , 2002, Molecular and Cellular Biology.

[77]  I. Kanazawa,et al.  α-Synuclein Affects the MAPK Pathway and Accelerates Cell Death* , 2001, The Journal of Biological Chemistry.

[78]  E. Martegani,et al.  Cloning and Characterization of Mouse UBPy, a Deubiquitinating Enzyme That Interacts with the Ras Guanine Nucleotide Exchange Factor CDC25Mm/Ras-GRF1* , 2001, The Journal of Biological Chemistry.

[79]  O. Bernard,et al.  Cytoskeletal Changes Regulated by the PAK4 Serine/Threonine Kinase Are Mediated by LIM Kinase 1 and Cofilin* , 2001, The Journal of Biological Chemistry.

[80]  J. Condeelis,et al.  How is actin polymerization nucleated in vivo? , 2001, Trends in cell biology.

[81]  B. Lim,et al.  Androgen Receptor Specifically Interacts with a Novel p21-activated Kinase, PAK6* , 2001, The Journal of Biological Chemistry.

[82]  A. Minden,et al.  Activated PAK4 Regulates Cell Adhesion and Anchorage-Independent Growth , 2001, Molecular and Cellular Biology.

[83]  N. Gnesutta,et al.  The Serine/Threonine Kinase PAK4 Prevents Caspase Activation and Protects Cells from Apoptosis* , 2001, The Journal of Biological Chemistry.

[84]  L. Lim,et al.  Interaction between PAK and Nck: a Template for Nck Targets and Role of PAK Autophosphorylation , 2000, Molecular and Cellular Biology.

[85]  B. Calabretta,et al.  Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. , 1999, Cancer research.

[86]  G. Bokoch,et al.  Inhibition of myosin light chain kinase by p21-activated kinase. , 1999, Science.

[87]  A. Abo,et al.  PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia , 1998, The EMBO journal.

[88]  H. Jäckle,et al.  A protein related to p21-activated kinase (PAK) that is involved in neurogenesis in the Drosophila adult central nervous system , 1998, Current Biology.

[89]  S. Lowe,et al.  Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.

[90]  C. Walsh,et al.  PAK3 mutation in nonsyndromic X-linked mental retardation , 1998, Nature Genetics.

[91]  G. Drewes,et al.  MARK, a Novel Family of Protein Kinases That Phosphorylate Microtubule-Associated Proteins and Trigger Microtubule Disruption , 1997, Cell.

[92]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[93]  J. Yokota,et al.  Biological properties and gene expression associated with metastatic potential of human osteosarcoma , 2004, Clinical & Experimental Metastasis.

[94]  Maria Carla Parrini,et al.  Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1. , 2002, Molecular cell.

[95]  S. Balk,et al.  AR and ER interaction with a p21-activated kinase (PAK6). , 2002, Molecular endocrinology.

[96]  C A Morris,et al.  Williams syndrome and related disorders. , 2000, Annual review of genomics and human genetics.